ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Neuren granted Type B Meeting with FDA for Rett syndrome
Published: 20/07/17, 12:44pm (AEST)•1 pages